Modifications of membrane cholesterol content affects electrical properties and prolactin release of cultured pituitary cells.
Treatment of cloned pituitary cells (GH3/B6) with cholesterol-enriched liposomes, which presumably increases membrane cholesterol content, affects the passive and active electrophysiological properties and stimulates the release of prolactin (PRL).